6 Reksa Dana Terbaik dengan FP1 / Salarius Pharmaceuticals, Inc. (DB)

Salarius Pharmaceuticals, Inc.

DE ˙ DB

€ 12.91 ↑0.01 (0.08%)

2019-07-25
BAHAGING PRESYO

6 Reksa Dana Terbaik dengan DE:FP1 / Salarius Pharmaceuticals, Inc.

Halaman ini menampilkan semua reksa dana yang telah melaporkan posisi di DE:FP1 / Salarius Pharmaceuticals, Inc.. Baris berwarna hijau menunjukkan posisi baru. Klik tautan ikon untuk melihat riwayat transaksi selengkapnya.

Tingkatkan ke versi premium untuk membuka data premium dan ekspor ke Excel. .

Tanggal File	Sumber	Investor		Ketik	Presyo ng Avg (Silangan)	Saham	Δ Saham (%)	Dilaporkan Nilai ($1000)	Nilai Δ (%)	Alokasi Port (%)
2025-04-25	NP	FNCMX - Fidelity Nasdaq Composite Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				0	-100.00	0
2025-08-27	NP	VEXMX - Vanguard Extended Market Index Fund Investor Shares This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				1,820	0.00	2	0.00
2025-07-24	NP	FSMAX - Fidelity Extended Market Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				9,353	64.78	7	16.67
2025-03-28	NP	USMIX - Extended Market Index Fund				0	-100.00	0
2025-07-24	NP	FCFMX - Fidelity Series Total Market Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				7,028	323.63	5	400.00
2025-07-24	NP	FSKAX - Fidelity Total Market Index Fund This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				321	0.00	0

Other Listings

US:SLRX

US$ 4.71

Fintel data has been cited in the following publications:

© 2015-2025 Fintel Ventures LLC. All rights reserved. Fintel® is a registered trademark.

This website is provided “as is” without any representations or warranties, express or implied. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Nothing on this website constitutes, or is meant to constitute, advice of any kind. If you require advice in relation to any financial matter you should consult an appropriate professional.